Impact of radiation dose on locoregional control and survival on squamous cell carcinoma of anal canal

Radiotherapy and Oncology

Volumn 95, Issue 3, 2010, Pages 283-287

  Engineer, Reena ^a   Mallik, Suman ^a   Mahantshetty, Umesh ^a   Shrivastava, ShyamKishore ^a  

^a TATA MEMORIAL HOSPITAL   (India)

Author keywords

Anal canal; Cancer; Prognostic factors; Radiation dose

Indexed keywords

FLUOROURACIL; MITOMYCIN C;

ADULT; AGED; ANUS CARCINOMA; ARTICLE; BLOOD TOXICITY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER SURVIVAL; FEMALE; GASTROINTESTINAL TOXICITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; RADIATION INJURY; SKIN TOXICITY; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; SURVIVAL TIME; TREATMENT RESPONSE; UROGENITAL TRACT DISEASE;

ADULT; AGED; AGED, 80 AND OVER; ANAL CANAL; ANUS NEOPLASMS; CARCINOMA, SQUAMOUS CELL; COLOSTOMY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; RADIOTHERAPY DOSAGE;

EID: 77952585230     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2010.04.013     Document Type: Article

References (24)

1. Landis S.H., Murray T., and Bolden S. Cancer statistics, 1999. CA Cancer J Clin 49 (1999) 8-31
2. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2006. CA Cancer J Clin 56 (2006) 106-130
3. National Cancer Registry Report. ICMR; 2001-2004. p. 78-154.
4. Miles E. A method of performing abdominoperineal excision for carcinoma of the rectum and of the terminal portion of the pelvic colon. Lancet 2 (1908) 1812-1813
5. Binkley G.E. Epidermoid carcinoma of the anus and rectum: review of 125 cases. Am J Surg 79 (1950) 90-95
6. UKCCCR Anal Cancer Trial Working Party. Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. UK Coordinating Committee on Cancer Research. Lancet 348 (1996) 1049-1054
7. Bartelink H., Roelofsen F., Eschwege F., et al. Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. J Clin Oncol 15 (1997) 2040-2049
8. Flam M., John M., Pajak T.F., et al. Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study. J Clin Oncol 14 (1996) 2527-2539
9. Cummings B.J., Keane T.J., O'Sullivan B., et al. Epidermoid anal cancer: treatment by radiation alone or by radiation and 5-fluorouracil with and without mitomycin C. Int J Radiat Oncol Biol Phys 21 (1991) 1115-1125
10. Green F.L., Page D.L., and Flemming I.D. American Joint Committee on cancer, cancer staging handbook. 6th ed. (2002), Springer, New York
11. Peiffert D., Bey P., Pernot M., et al. Conservative treatment by irradiation of epidermoid cancers of the anal canal: prognostic factors of tumoral control and complications. Int J Radiat Oncol Biol Phys 37 (1997) 313-324
12. Widder J., Kastenberger R., Fercher E., Schmid R., Langendijk J.A., Dobrowsky W., et al. Radiation dose associated with local control in advanced anal cancer: retrospective analysis of 129 patients. Radiother Oncol 87 (2008) 367-375
13. Myerson R.J., Kong F., Birnbaum E.H., et al. Radiation therapy for epidermoid carcinoma of the anal canal, clinical and treatment factors associated with outcome. Radiother Oncol 61 (2001) 15-22
14. Ajani J.A., Winter K.A., Gunderson L.L., Pedersen J., Benson III A.B., Thomas Jr. C.R., et al. US intergroup anal carcinoma trial: tumor diameter predicts for colostomy. J Clin Oncol 27 (2009) 1116-1121
15. Das P., Bhatia S., Eng C., Ajani J.A., Skibber J.M., Rodriguez-Bigas M.A., et al. Predictors and patterns of recurrence after definitive chemoradiation for anal cancer. Int J Radiat Oncol Biol Phys 68 (2007) 794-800
16. Constantinou E.C., Daly W., Fung C.Y., et al. Time-dose considerations in the treatment of anal cancer. Int J Radiat Oncol Biol Phys 39 (1997) 651-657 [Oncol Invest 1994;2:152-6]
17. Ferrigno R., Nakamura R.A., Dos Santos Novaes P.E., Pellizzon A.C., Maia M.A., Fogarolli R.C., et al. Radiochemotherapy in the conservative treatment of anal canal carcinoma: retrospective analysis of results and radiation dose effectiveness. Int J Radiat Oncol Biol Phys 61 (2005) 1136-1142
18. Rich T.A., Ajani J.A., Morrison W.H., Ota D., and Levin B. Chemoradiation therapy for anal cancer: radiation plus continuous infusion of 5-fluorouracil with or without cisplatin. Radiother Oncol 27 (1993) 209-215
19. Deniaud-Alexandre E., Touboul E., Tiret E., et al. Epidermoid carcinomas of the anal canal treated with definitive radiation therapy in a series of 305 patients. Cancer Radiother 7 (2003) 237-253
20. John M., Pajak T., Flam M., et al. Dose escalation in chemoradiation for anal cancer: preliminary results of RTOG 92-08. Cancer J Sci Am 2 (1996) 205-211
21. John Gerard J.P., Ayzac L., Hun D., et al. Treatment of anal canal carcinoma with high dose radiation therapy and concomitant fluorouracil-cisplatinum. Long-term results in 95 patients. Radiother Oncol 46 (1998) 249-256
22. Conroy T., Ducreux M., Lemanski C., et al. Treatment intensification by induction chemotherapy (ICT) and radiation dose escalation in locally advanced squamous cell anal canal carcinoma (LAAC): definitive analysis of the intergroup ACCORD 03 trial. J CO 27 (2009) 4033 [Meeting Abstracts]
23. Konski A., Garcia Jr. M., John M., et al. Evaluation of planned treatment breaks during radiation therapy for anal cancer: update of RTOG 92-08. Int J Radiat Oncol Biol Phys 72 (2008) 114-118
24. Weber D.C., Kurtz J.M., and Allal A.S. The impact of gap duration on local control in anal canal carcinomatreated by split-course radiotherapy and concomitant chemotherapy. Int J Radiat Oncol Biol Phys 50 (2001) 675-680